Ruth L. Cromie

Ruth L. Cromie

Auto-generated profile, based on publicly available information

Ruth L. Cromie

Wildfowl & Wetlands Trust, Slimbridge, Gloucestershire, UK

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
PMPhoebe Maund
Phoebe Maund
KIKatherine Irvine
Katherine Irvine
JRJonathan Peter Reeves
Jonathan Peter Reeves
ESEmily Strong
Emily Strong
RCRuth Cromie
Ruth Cromie
ZDZoe Davies
Zoe Davies
Nature-based health interventions (NBIs) for the treatment of poor mental health are becoming increasingly common, yet evidence to support their effectiveness is lacking. We conduct a pilot study of a six-week intervention, aiming to engage individuals with wetland nature for the treatment of anxiety and/or depression. We employed a mixed methods design, using questionnaires, focus groups and semi-structured interviews to evaluate the intervention from the perspective of participants (n = 16) and healthcare professionals (n = 2). Results demonstrate significant improvements in mental health across a range of indicators, including mental wellbeing (Warwick and Edinburgh Mental Wellbeing Scale), anxiety (Generalised Anxiety Disorder-7), stress (Perceived Stress Scale) and emotional wellbeing (Positive and Negative Affect Schedule). Participants and healthcare professionals cited additional outcomes including improved physical health and reduced social isolation. The wetland site provided a sense of escape from participants’ everyday environments, facilitating relaxation and reductions in stress. Wetland staff knowledge of the natural world, transportation and group organisation also played a considerable role in the intervention’s success. These aspects should be considered in future and existing NBIs to maximise benefits to participants. We propose NBIs based in wetlands are an effective therapy option for individuals diagnosed with anxiety and/or depression.

16 March 2019 in AMBIO
Verified
Journal Article
Open access
PDF file
DPDeborah J. Pain
Deborah J. Pain
IDIan Dickie
Ian Dickie
RGRhys E. Green
Rhys E. Green
NKNiels Kanstrup
Niels Kanstrup
RCRuth Cromie
Ruth Cromie
A proposed European Union (EU)-wide restriction on the use of lead gunshot for shooting in and over wetlands estimated that the societal benefits of a restriction outweighed costs, despite few identified benefits being quantified economically. A subsequent Annex XV Investigation Report on the evidence of impacts of lead ammunition in terrestrial environments concluded that additional measures to control its use are warranted, although to date this has not been further evaluated. To help inform this process, we review the literature and undertake new analyses to estimate the costs of continued use of lead ammunition associated with impacts on wildlife, people and the environment. We estimate minimum annual direct costs across the EU and Europe of c. €383 million–€960 million and €444 million–€1.3 thousand million respectively. The value that society places on being able to avoid these losses, estimated using a ‘willingness to pay’ approach, was c. €2.2 thousand million for wildfowl alone. Our estimated costs of the continued use of lead ammunition across the EU appear to be considerably greater than the likely costs of switching to non‐toxic alternative ammunition types, although these have not been formally estimated in full.

26 July 2022 in Ecological Solutions and Evidence
Verified
Journal Article
Open access
KBKatie M. Beckmann
Katie M. Beckmann
RCRuth L. Cromie
Ruth L. Cromie
ASAnthony W. Sainsbury
Anthony W. Sainsbury
GHGeoff M. Hilton
Geoff M. Hilton
JEJohn G. Ewen
John G. Ewen
RKRichard Kock
Richard Kock
It is intuitive that the health status of wildlife might influence conservation translocation outcomes, however, health as a topic has received limited attention in the conservation translocation literature. We determined the forms and frequency of disease and other biological problems reported in translocated animals and plants, and in populations linked to translocation, and associations between their mention and translocation ‘success’. From these problems we deduced the forms of ill‐health potentially associated with conservation translocation and developed contextual frameworks to inform health management. Using described selection criteria, a subset of case studies of animal and plant conservation translocation from the IUCN's ‘Global Reintroduction Perspectives’ series (2008–2018) was reviewed. Self‐reported information describing or implying mortality, ill‐health or reproductive compromise was extracted and categorized as a ‘disease’ or other biological problem. Problems explicitly described as a ‘major difficulty’, ‘major lesson’ or ‘reason for failure’ were termed ‘notable’. We specified the conditions representing ill‐health and created diagrams illustrating their relationships to other biological problems and processes, and management measures. Notable ‘disease’ problems such as infection, (as in stress‐related) and husbandry‐related disorders were reported in 30% of 295 reviewed case studies and were more likely to be mentioned in less ‘successful’ projects (P < 0.05, χ2 test). Other biological problems, in particular predation, adverse climate or weather, and anthropogenic trauma, were commonly reported (66% of 295 studies), especially post‐release. When present, disease may be an important obstacle to translocation success. The negative health impacts of other, apparently common post‐release problems also merit acknowledgement. A broad spectrum of disease and other health‐related problems can potentially occur in conservation translocations and impact conservation and animal welfare outcomes. We suggest health management of translocation has three broad roles: to mitigate disease risks posed to other animals, plants and humans; to mitigate threats to the health of translocated individuals themselves; and to preserve and build their resilience and adaptive capacity, given the apparent high frequency of post‐release problems. We advocate a stronger emphasis on fostering health as opposed to solely preventing disease. This is directly and indirectly dependent on a range of related project management actions and on multi‐disciplinary expertise.

1 March 2000 in Developmental & Comparative Immunology
Verified
Journal Article
Closed access
RCRuth L. Cromie
Ruth L. Cromie
NANeville J. Ash
Neville J. Ash
MBMartin J. Brown
Martin J. Brown
JSJohn L. Stanford
John L. Stanford

1 July 2019 in AMBIO
Verified
Journal Article
Closed access
PDF file
RCRuth Cromie
Ruth Cromie
JNJulia Newth
Julia Newth
ESEmily Strong
Emily Strong

1 September 1993 in Avian Pathology
Verified
Journal Article
Open access
RCRuth L. Cromie
Ruth L. Cromie
MBM. J. Brown
M. J. Brown
NFN. A. Forbes
N. A. Forbes
JMJenny Morgan
Jenny Morgan
JSJ. L. Stanford
J. L. Stanford
To control the epizootic of avian tuberculosis within the collections of captive wildfowl of The Wildfowl and Wetlands Trust an efficacious vaccine and a reliable diagnostic test are required. A number of potential diagnostic tests were compared for sensitivity and specificity using a flock of 178 feral barnacle geese (Branta leucopsis) at The Wildfowl and Wetland Trust's centre at Slimbridge, Gloucestershire. Evaluations were made of: serodiagnosis by an enzyme‐linked immunosorbent assay (ELISA); agglutination of a suspension of killed Mycobacterium avium using both whole blood and serum; and haematological analysis. Necropsy findings confirmed the ELISA to be sensitive and specific, and capable of detecting the disease even at an early stage. The agglutination tests were quick and easy to perform although a number of false positives and negatives did occur. The haematological analysis was found to be less sensitive. ELISA and agglutination tests are now being used to screen the birds in the collections.